- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03838458
Molecular and Structural Comparison of Hypospadic and Normal Children Prepuces
April 25, 2020 updated by: Irem Inanc, Trakya University
Comparison of Structural and Molecular Genetic Properties Between Normal and Hypospadic Children's Prepuces
The aim of this study is to compare prepuce tissue samples from healthy male children who applied for circumcision and children with isolated hypospadias.
Estrogen receptor 1 (ER1), androgen receptor (AR), FGFR2, transforming growth factor beta (TGF beta) and HOXA13 gene expression in the prepuce is planned to investigate via polymerase chain reaction (PCR) method.
Mucosal vascular and nerve densities, and extracellular matrix density of laminin and collagen protein is planned to investigate via immunohistochemical examination.
Study Overview
Status
Completed
Conditions
Study Type
Observational
Enrollment (Actual)
52
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Edirne, Turkey, 22030
- Trakya University Faculty of Medicine
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
No older than 18 years (Child, Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
Male
Sampling Method
Non-Probability Sample
Study Population
0-18 years old pediatric male population, patients with isolated hypospadias are study group, patients with planned circumcision are control group.
Description
Inclusion Criteria:
- To apply for circumcision, not to have any genitourinary abnormalities/conditions for control group.
- To have isolated hypospadias for study group.
Exclusion Criteria:
- To have genitourinary surgery before.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
Study
Children with isolated hypospadias
|
|
Control
Children with planned circumcision
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Genetic analysis 1
Time Frame: 1 year
|
Androgen receptor (AR) gene PCR analysis
|
1 year
|
|
Genetic analysis 2
Time Frame: 1 year
|
Estrogen receptor 1 (ER1) gene PCR analysis
|
1 year
|
|
Genetic analysis 3
Time Frame: 1 year
|
FGFR2 gene PCR analysis
|
1 year
|
|
Genetic analysis 4
Time Frame: 1 year
|
TGF beta gene PCR analysis
|
1 year
|
|
Genetic analysis 5
Time Frame: 1 year
|
HOXA13 gene PCR analysis
|
1 year
|
|
Immunohistochemical study 1
Time Frame: 1 year
|
Mucosal vessel density is planned to determine via CD34
|
1 year
|
|
Immunohistochemical study 2
Time Frame: 1 year
|
Mucosal nerve density is planned to determine via PGP 9.5
|
1 year
|
|
Histological study 1
Time Frame: 1 year
|
Laminin is planned to determine in extracellular matrix via light microscope
|
1 year
|
|
Histological study 2
Time Frame: 1 year
|
Collagen is planned to determine in extracellular matrix via light microscope
|
1 year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Dincer Avlan, Profesor, MD, Trakya University Faculty of Medicine, Pediatric Surgery Department
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 7, 2019
Primary Completion (Actual)
January 7, 2020
Study Completion (Actual)
March 10, 2020
Study Registration Dates
First Submitted
February 8, 2019
First Submitted That Met QC Criteria
February 9, 2019
First Posted (Actual)
February 12, 2019
Study Record Updates
Last Update Posted (Actual)
April 28, 2020
Last Update Submitted That Met QC Criteria
April 25, 2020
Last Verified
April 1, 2020
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- Hypospadic prepuce structure
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.